Vitamin E's benefits for improving PCOS patients' metabolic and hormonal health, Fonterra's cultured milk drink ambitions, and iron nutrition innovation from Nestle, Wellnex Life are some of the most-read stories last month.
Vitamin E supplementation can positively affect polycystic ovary syndrome (PCOS) patients' metabolic and hormonal parameters, according to a systematic review and meta-analysis.
Fonterra has launched its first brand of cultured milk drinks in Singapore, where it hopes the low sugar, novel flavours and evidence-backed probiotic strains will resonate with the consumers.
Chemist Warehouse says it is 'on a mission for expansion' in Australia's growing beauty-from-within retail sector.
Suppliers selling functional ingredients derived from palm oil, such as tocotrienols and carotene, are expecting pressures around working capital and lead time,with Indonesia's palm oil export ban tightening supplies and pushing prices up.
BIO & ME, the consumer health brand of Singapore-based gut microbiome firm AMILI, has launched five probiotic formulations to target immunity, well-being, energy, mental health and strength – all tailored to the Asian population.
Kao has launched two new healthy ageing related Foods with Function Claims (FFCs) in Japan, targeted at improving mobility and cognitive function.
Future infant nutrition research should look into the link between nutrients and gut-brain axis and even its impacts decades later when a child reaches adulthood, instead of merely mimicking human breast milk and focusing on only height and weight gain.
Nestle China has launched three new infant formulas containing human milk oligosaccharides (HMOs) that cater to newborns allergic to cow's milk protein and also benefit their immune system.
Meiji is re-entering Thailand's toddler formula market with a powder cube product, 17 years after it wound up its business in the country due to an international currency crisis.
Nestle and Australia's Wellnex Life are hoping to create awe in the iron category with new products that tap new innovations to boost bioavailability.
